Learning from the first: a qualitative study of the psychosocial benefits and treatment burdens of long‐acting cabotegravir/rilpivirine among early adopters in three U.S. clinics.

Saved in:
Bibliographic Details
Title: Learning from the first: a qualitative study of the psychosocial benefits and treatment burdens of long‐acting cabotegravir/rilpivirine among early adopters in three U.S. clinics.
Authors: Christopoulos, Katerina A.1 (AUTHOR) katerina.christopoulos@ucsf.edu, Smith, Mollie B.2 (AUTHOR), Pareek, Priyasha3 (AUTHOR), Dawdani, Alicia4 (AUTHOR), Erguera, Xavier A.1 (AUTHOR), Dance, Kaylin V.5 (AUTHOR), Walker, Ryan S.6 (AUTHOR), Grochowski, Janet1 (AUTHOR), Mayorga‐Munoz, Francis1 (AUTHOR), Hickey, Matthew D.1 (AUTHOR), Johnson, Mallory O.1 (AUTHOR), Sauceda, John1 (AUTHOR), Gutierrez, Jose I.7 (AUTHOR), Montgomery, Elizabeth T.8,9 (AUTHOR), Colasanti, Jonathan A.3,5 (AUTHOR), Collins, Lauren F.3,5 (AUTHOR), McNulty, Moira C.4 (AUTHOR), Koester, Kimberly A.1 (AUTHOR)
Source: Journal of the International AIDS Society. Nov2024, Vol. 27 Issue 11, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17582652
DOI:10.1002/jia2.26394